retatrutide peptide Retatrutide Peptide | Research Peptide Vial

GLP-1 and health: Beyond weight loss in the Ozempic era

Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation ...

Weight loss advice is everywhere, but what's really effective for you? Mehak Gandhi, MD, with HHC Medical Group, explains the role GLP-1 medications can play in weight management, who might benefit most,

The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, Retatrutide

Male Breast Reduction After Weight Loss | Effective Treatments